Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial

scientific article published on 08 December 2020

Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.7326/M20-6519
P932PMC publication ID7732017
P698PubMed publication ID33284679

P50authorAnna WaldQ41122225
Connie CelumQ42571941
Michael Paasche-OrlowQ42908767
Miriam K. LauferQ53731891
Christine JohnstonQ56501593
Meagan BollesQ56589072
Harald HaugenQ58413476
Raphael J LandovitzQ59196629
Kathleen NeuzilQ76169016
Alexander L. GreningerQ81925135
Ruanne BarnabasQ89357484
Jared M BaetenQ89443633
Anna BershteynQ89475473
Lorna E ThorpeQ89484361
Risa HoffmanQ89630094
Mark H WenerQ91721449
Elizabeth R BrownQ100939489
Helen C Stankiewicz KaritaQ104104998
Angelica KottkampQ104104999
Katherine K ThomasQ104105000
Meighan L KrowsQ108887345
Lara KidoguchiQ108887349
Torin T SchaafsmaQ108887352
P2093author name stringMeei-Li Huang
Susan Morrison
Keith R Jerome
Patricia J Kissinger
Kristopher Paolino
Helen Y Chu
Alfred Luk
P921main subjectsevere acute respiratory syndromeQ103177
P577publication date2020-12-08
P1433published inAnnals of Internal MedicineQ564416
P1476titleHydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial

Search more.